tiprankstipranks
Advertisement
Advertisement

MTVA Stock Latest News

Fein Reiterates Buy on MetaVia as New Phase 1 Liver Data De-Risk DA-1726 and Support Unchanged $20 Price Target
RatingsFein Reiterates Buy on MetaVia as New Phase 1 Liver Data De-Risk DA-1726 and Support Unchanged $20 Price Target
7d ago
MTVA
MetaVia’s DA-1726 shows efficacy in obesity and MASH presentations
PremiumThe Fly
MetaVia’s DA-1726 shows efficacy in obesity and MASH presentations
8d ago
MTVA
MetaVia highlights promising Phase 1 obesity drug data
PremiumCompany Announcements
MetaVia highlights promising Phase 1 obesity drug data
8d ago
8K
MTVA
3 Penny Stocks to Watch Now, 5/21/26
PremiumMarket News
3 Penny Stocks to Watch Now, 5/21/26
14d ago
HCWB
MTVA
Analyst Reiterates Buy on MetaVia, Maintains $8 Price Target Amid Promising Metabolic Pipeline and Upcoming Data Catalysts
PremiumRatings
Analyst Reiterates Buy on MetaVia, Maintains $8 Price Target Amid Promising Metabolic Pipeline and Upcoming Data Catalysts
14d ago
MTVA
Fein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20
PremiumRatingsFein Reiterates Buy on MetaVia, Keeps DA-1726-Driven Price Target Unchanged at $20
17d ago
MTVA
MetaVia Showcases Key Cardiometabolic Data at ADA 2026
Premium
Company Announcements
MetaVia Showcases Key Cardiometabolic Data at ADA 2026
17d ago
8K
MTVA
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data
Premium
Company Announcements
MetaVia Highlights Strong DA-1726 Phase 1 Weight-Loss Data
21d ago
8K
MTVA
MetaVia to Present New DA-1726 Obesity Data at EASL
PremiumCompany Announcements
MetaVia to Present New DA-1726 Obesity Data at EASL
24d ago
8K
MTVA
MetaVia Advances DA-1726 Obesity Trial With First Patient
PremiumCompany Announcements
MetaVia Advances DA-1726 Obesity Trial With First Patient
2M ago
8K
MTVA
MetaVia says first patient dosed in Part 3 of Phase 1 trial of DA-1726
PremiumThe Fly
MetaVia says first patient dosed in Part 3 of Phase 1 trial of DA-1726
2M ago
MTVA
MetaVia (MTVA): Differentiated Dual-Agonist Obesity Therapy and Solid Cash Runway Underpin Buy Rating
PremiumRatings
MetaVia (MTVA): Differentiated Dual-Agonist Obesity Therapy and Solid Cash Runway Underpin Buy Rating
2M ago
MTVA
Maintaining Buy on MetaVia: Advancing DA-1726 Clinical Profile and Differentiated Obesity/MASH Strategy Despite Reduced Target Price
PremiumRatingsMaintaining Buy on MetaVia: Advancing DA-1726 Clinical Profile and Differentiated Obesity/MASH Strategy Despite Reduced Target Price
2M ago
MTVA
MetaVia Updates Investor Strategy for Obesity and MASH
Premium
Company Announcements
MetaVia Updates Investor Strategy for Obesity and MASH
2M ago
8K
MTVA
MetaVia: Cash position adequate to fund operations into 4Q26
Premium
The Fly
MetaVia: Cash position adequate to fund operations into 4Q26
2M ago
MTVA
MetaVia CEO says ‘significant progress advancing our cardiometabolic portfolio’
PremiumThe Fly
MetaVia CEO says ‘significant progress advancing our cardiometabolic portfolio’
2M ago
MTVA
Metavia Inc. (MTVA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Metavia Inc. (MTVA) Q4 Earnings Cheat Sheet
2M ago
MTVA
MetaVia Advances DA-1726 Obesity Drug into Phase 1 Part 3
PremiumCompany Announcements
MetaVia Advances DA-1726 Obesity Drug into Phase 1 Part 3
3M ago
8K
MTVA
MetaVia announces IRB at Clinical Pharmacology of Miami approved Phase 1 study
PremiumThe Fly
MetaVia announces IRB at Clinical Pharmacology of Miami approved Phase 1 study
3M ago
MTVA
MetaVia expands global patent protection for vanoglipel into 2035
PremiumThe FlyMetaVia expands global patent protection for vanoglipel into 2035
3M ago
MTVA
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
3M ago
IPI
MSS
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
3M ago
IPI
MSS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >